Pittsburgh, PANCT06244199Now EnrollingIRB Ready

Cardiovascular Diseases Clinical Trial in Pittsburgh, PA

Access cutting-edge cardiovascular diseases treatment through this clinical trial at a research site in Pittsburgh. Study-provided care at no cost to qualified participants.

Sponsored by VA Office of Research and Development

Quick Self-Assessment

See if you qualify for this Pittsburgh location

Preparing your pre-screening questions…

Expert Care in Pittsburgh

Access cardiovascular diseases specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related cardiovascular diseases treatment provided free

Apply for This Pittsburgh Location

Check if you qualify for this cardiovascular diseases clinical trial in Pittsburgh, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Pittsburgh

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Pittsburgh site if eligible
  4. 4Begin participation

About This Cardiovascular Diseases Study in Pittsburgh

Cardiac rehabilitation (CR) is a secondary prevention program for patients with cardiovascular disease (CVD). It is especially valuable as CVD increasingly occurs in combination with comorbidity, frailty, and complexities of care that predispose patients to functional decline, disability, and high costs. Still, few Veterans participate in CR, in part because of the difficult logistics to attend. Promising Practice home-based CR (HBCR) was developed to increase CR participation, but many Veterans remain too limited by comorbidity and frailty for participation. A Transition to CR (T2CR) intervention is a face-to-face program that fosters vital skills, education, insights, motivation, and patient-provider relationships conducive to successful HBCR thereafter. This study compares Veterans eligible for CR who are randomized to T2CR intervention versus usual care. Differences in functional capacity, HBCR participation, and healthy days at home are compared over one year. Patients' experiences and providers' perspectives of barriers and facilitators to T2CR are also compared.

Sponsor: VA Office of Research and Development

Who Can Participate

Inclusion Criteria

Eligible candidates will consist of male and female Veterans hospitalized with:
ischemic heart disease (acute myocardial infarction or stable ischemia)
revascularization (coronary artery bypass grafting or percutaneous coronary intervention)
valvular heart disease (surgical or percutaneous intervention for mitral regurgitation or aortic stenosis)
or heart failure (with reduced or preserved ejection fraction)
All will be recruited while initially hospitalized and must express willingness to consider cardiac rehabilitation as a treatment option, including the possibility of the intervention which could possibly extend the length of their hospitalization (for 2 days maximum).
Study candidates must also be English speaking and able to provide written informed consent

Exclusion Criteria

Veterans with unstable medical condition as indicated by history, physical exam, and/or laboratory findings end-stage disease likely to be fatal within 12 months
severe cognitive impairment (MiniCog score 0-2)
history of addictive or behavioral issues that confound safe administration of HBCR
hearing loss that interferes with participation in the trial
living in a long-term care living situation prior to the time of hospitalization, no plans to return to independent living after the hospitalization

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Pittsburgh?

Yes, this clinical trial (NCT06244199) has an active research site in Pittsburgh, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Cardiovascular Diseases Treatment Options in Pittsburgh, PA

If you're searching for cardiovascular diseases treatment options in Pittsburgh, PA, this clinical trial (NCT06244199) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Pittsburgh research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cardiovascular diseases specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all cardiovascular diseases clinical trials near you to find additional studies recruiting in your area.

More Heart Disease Trials in Pittsburgh, PA

See all heart disease clinical trials recruiting in Pittsburgh — not just this study.

Browse Heart Disease Trials in Pittsburgh

Ready to Join in Pittsburgh?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Pittsburgh, PA